Financials
- Market Capitalization 4.23 B
- Employee 624
- Founded 2009
- CEO Chad Robins
- Website www.adaptivebiotech.com
- Headquarter Washington, United States
- FIGI BBG001J2PFF5
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-41.64
Fiyat/satışlar oranı
8.9
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 1366 | DNTH Dianthus Therapeutics, Inc. - Common Stock | 82.37 USD | -0.07% | -6.86% | -23.98% | +138.34% | 4.61 B USD | ||
| 1420 | EWTX Edgewise Therapeutics, Inc. - Common Stock | 39.06 USD | -0.43% | -5.99% | -11.19% | +156.47% | 4.24 B USD | ||
| 1458 | TNGX Tango Therapeutics, Inc. - Common Stock | 23.81 USD | +5.49% | +2.81% | -0.71% | +228.41% | 4.01 B USD | ||
| 1476 | RLAY Relay Therapeutics, Inc. - Common Stock | 17.88 USD | +2.70% | -5.89% | -5.65% | +170.91% | 3.92 B USD |